Cantor Sharon, Drapkin Ronny, Zhang Fan, Lin Yafang, Han Juliana, Pamidi Sushmita, Livingston David M
Department of Cancer Biology, University of Massachusetts Medical School, Lazare Research Building, Worcester, MA 01605, USA.
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2357-62. doi: 10.1073/pnas.0308717101.
BACH1 is a nuclear protein that directly interacts with the highly conserved, C-terminal BRCT repeats of the tumor suppressor, BRCA1. Mutations within the BRCT repeats disrupt the interaction between BRCA1 and BACH1, lead to defects in DNA repair, and result in breast and ovarian cancer. BACH1 is necessary for efficient double-strand break repair in a manner that depends on its association with BRCA1. Moreover, some women with early-onset breast cancer and no abnormalities in either BRCA1 or BRCA2 carry germline BACH1 coding sequence changes, suggesting that abnormal BACH1 function contributes to tumor induction. Here, we show that BACH1 is both a DNA-dependent ATPase and a 5'-to-3' DNA helicase. In two patients with early-onset breast cancer who carry distinct germline BACH1 coding sequence changes, the resulting proteins are defective in helicase activity, indicating that these sequence changes disrupt protein function. These results reinforce the notion that mutant BACH1 participates in breast cancer development.
BACH1是一种核蛋白,它直接与肿瘤抑制因子BRCA1高度保守的C末端BRCT重复序列相互作用。BRCT重复序列内的突变会破坏BRCA1与BACH1之间的相互作用,导致DNA修复缺陷,并引发乳腺癌和卵巢癌。BACH1以依赖于其与BRCA1关联的方式,对高效双链断裂修复是必需的。此外,一些患有早发性乳腺癌且BRCA1和BRCA2均无异常的女性携带种系BACH1编码序列变化,这表明BACH1功能异常有助于肿瘤诱导。在此,我们表明BACH1既是一种依赖DNA的ATP酶,也是一种5'至3' DNA解旋酶。在两名携带不同种系BACH1编码序列变化的早发性乳腺癌患者中,所产生的蛋白质在解旋酶活性方面存在缺陷,这表明这些序列变化破坏了蛋白质功能。这些结果强化了突变型BACH1参与乳腺癌发展的观点。